Resistance Analysis of Baseline and Treatment-Emergent Variants in Hepatitis C Virus Genotype 1 in the AVIATOR Study with Paritaprevir-Ritonavir, Ombitasvir, and Dasabuvir

por Krishnan, Preethi, Tripathi, Rakesh, Schnell, Gretja, Reisch, Thomas, Beyer, Jill, Irvin, Michelle, Xie, Wangang, Larsen, Lois, Cohen, Daniel, Podsadecki, Thomas, Pilot-Matias, Tami, Collins, Christine
Publicado 2015

Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir

por Schnell, Gretja, Krishnan, Preethi, Tripathi, Rakesh, Beyer, Jill, Reisch, Thomas, Irvin, Michelle, Dekhtyar, Tatyana, Lu, Liangjun, Ng, Teresa I., Xie, Wangang, Pilot-Matias, Tami, Collins, Christine
Publicado 2018

Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical Trials

por Krishnan, Preethi, Pilot-Matias, Tami, Schnell, Gretja, Tripathi, Rakesh, Ng, Teresa I., Reisch, Thomas, Beyer, Jill, Dekhtyar, Tatyana, Irvin, Michelle, Xie, Wangang, Larsen, Lois, Mensa, Federico J., Collins, Christine
Publicado 2018

Integrated Resistance Analysis of CERTAIN-1 and CERTAIN-2 Studies in Hepatitis C Virus-Infected Patients Receiving Glecaprevir and Pibrentasvir in Japan

por Krishnan, Preethi, Schnell, Gretja, Tripathi, Rakesh, Beyer, Jill, Reisch, Thomas, Dekhtyar, Tatyana, Irvin, Michelle, Xie, Wangang, Fu, Bo, Burroughs, Margaret, Redman, Rebecca, Kumada, Hiromitsu, Chayama, Kazuaki, Collins, Christine, Pilot-Matias, Tami
Publicado 2018

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir

por Ng, Teresa I., Krishnan, Preethi, Pilot-Matias, Tami, Kati, Warren, Schnell, Gretja, Beyer, Jill, Reisch, Thomas, Lu, Liangjun, Dekhtyar, Tatyana, Irvin, Michelle, Tripathi, Rakesh, Maring, Clarence, Randolph, John T., Wagner, Rolf, Collins, Christine
Publicado 2017

Resistance characterization of hepatitis C virus genotype 2 from Japanese patients treated with ombitasvir and paritaprevir/ritonavir

por Schnell, Gretja, Tripathi, Rakesh, Krishnan, Preethi, Beyer, Jill, Reisch, Thomas, Irvin, Michelle, Dekhtyar, Tatyana, Setze, Carolyn, Rodrigues‐Jr, Lino, Alves, Katia, Burroughs, Margaret, Redman, Rebecca, Chayama, Kazuaki, Kumada, Hiromitsu, Collins, Christine, Pilot‐Matias, Tami
Publicado 2017

Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 Infection

por Ng, Teresa I., Pilot-Matias, Tami, Tripathi, Rakesh, Schnell, Gretja, Krishnan, Preethi, Reisch, Thomas, Beyer, Jill, Dekhtyar, Tatyana, Irvin, Michelle, Lu, Liangjun, Asatryan, Armen, Campbell, Andrew, Yao, Betty, Lovell, Sandra, Mensa, Federico, Lawitz, Eric J., Kort, Jens, Collins, Christine
Publicado 2018

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir

por Ng, Teresa I., Tripathi, Rakesh, Reisch, Thomas, Lu, Liangjun, Middleton, Timothy, Hopkins, Todd A., Pithawalla, Ron, Irvin, Michelle, Dekhtyar, Tatyana, Krishnan, Preethi, Schnell, Gretja, Beyer, Jill, McDaniel, Keith F., Ma, Jun, Wang, Guoqiang, Jiang, Li-Juan, Or, Yat Sun, Kempf, Dale, Pilot-Matias, Tami, Collins, Christine
Publicado 2017